From professional translators, enterprises, web pages and freely available translation repositories.
viral
ittardjata2,
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
viral,
virali,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
viral infection
infezzjoni virali
Last Update: 2017-04-26
Usage Frequency: 7
Quality:
hepatitis, viral
hepatitis, virali
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
viral infection;
infezzjoni
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
baseline viral load
linja bażi tat- tagħbija virali
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
rare: viral infection
rari: infezzjoni virali
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
viral infection, pharyngitis
infezzjonijiet virali, farinġite
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
if viral rebound occurs, resistance testing should be performed.
jekk isseħħ il-viral rebound, għandu jsir ittestjar għar-reżistenza.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
bacterial infections, viral infections,
infezzjonijiet ikkawżati minn batterja,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1).
l-għażla ta’ amprenavir tiddependi fuq it- testijiet tar-reżistenza ta’ l-individwu għall-vajrus u fuq l-istorja tal-kura tal-pazjent (ara 5.1).
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
the characteristics of the human source such as age, sex, results of microbiological and viral testing, exclusion criteria and country of origin shall be documented.
il-karatteristiċi tal-fonti umana bħall-età, is-sess, ir-riżultati u testing virali, kriterji ta’ esklużjoni u pajjiż ta’ oriġini għandhom jiġu dokumentati.
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
the choice of evotaz in adult patients should be based on individual viral resistance testing and the patient’s treatment history (see section 5.1).
l-għażla ta’ evotaz fil-pazjenti adulti għandha tkun ibbażata fuq ittestjar tar-reżistenza virali individwali u l-istorja tal-kura tal-pazjent (ara sezzjoni 5.1).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the choice of reyataz in treatment experienced patients should be based on individual viral resistance testing and the patient’ s treatment history (see section 5.1).
l- għażla ta ’ reyataz f’ pazjenti li diġà ħadu l- kura għandha tkun ibbażata fuq il- prova tar- reżistenza virali ta 'l- individwu u l- istorja tal- kura kollha li diġà ħa l- pazjent (ara sezzjoni 5. 1).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
subgroup analyses testing for heterogeneity of once versus twice daily demonstrated no significant effect of sex, age, or viral load at randomisation.
l-ittestjar tal-analiżi tas-subgrupp għall-eteroġeneità ta’ darba kontra darbtejn kuljum ma wera ebda effett sinifikanti tas-sess, età jew tagħbija virali fir-randomizzazzjoni.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
if any doubt exists, further evaluation, including mri scan preferably with contrast, csf testing for jc viral dna and repeat neurological assessments, should be considered.
jekk ikun hemm xi dubju, għandhom jiġu kkunsidrati aktar valutazzjonijiet, inkluż scan ta ’ l- mri preferibilment b’ kuntrast, ittestjar tas- csf għal dna jc virali u valutazzjonijiet newroloġiċi ripetuti.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
anti-virals
mediċini antivirali
Last Update: 2017-04-06
Usage Frequency: 1
Quality: